REGENERON PHARMACEUTICALS, INC. (REGN) Capital expenditures 2016–2025
REGENERON PHARMACEUTICALS, INC. (REGN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$898.4MFY2025 · since FY2016: $511.9M → $898.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $898.4M | +18.9% |
| FY2024 | $755.9M | +5.2% |
| FY2023 | $718.6M | +21.8% |
| FY2022 | $590.1M | +6.9% |
| FY2021 | $551.9M | -10.2% |
| FY2020 | $614.6M | +43.1% |
| FY2019 | $429.6M | +12.1% |
| FY2018 | $383.1M | +40.5% |
| FY2017 | $272.6M | -46.7% |
| FY2016 | $511.9M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice